Derma Numb Pain Relief Gel
NDC Package 70188-005-01
Package Information
Derma Numb Pain Relief (lidocaine hcl) gel is a medication used to prevent and relieve pain during certain medical procedures (such as inserting a tube into the urinary tract). This formulation utilizes a gel delivery system. Marketed by A.t.s. Laboratories, Llc, this product is identified by NDC 70188-005 and is authorized under FDA application M017.
Identification & Billing
- RxCUI: 1010077 - lidocaine HCl 4 % Topical Gel
- RxCUI: 1010077 - lidocaine hydrochloride 0.04 MG/MG Topical Gel
- RxCUI: 1010077 - lidocaine hydrochloride 4 % Topical Gel
- RxCUI: 1747492 - Derma Numb 4 % Topical Gel
- RxCUI: 1747492 - lidocaine hydrochloride 0.04 MG/MG Topical Gel [Derma Numb]
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 70188 - A.t.s. Laboratories, Llc
- 70188-005 - Derma Numb Pain Relief
- 70188-005-01 - 28 g in 1 PACKAGE
- 70188-005 - Derma Numb Pain Relief
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (70188-005). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 70188-005-01 identifies a specific commercial package of 28 g in 1 package of Derma Numb Pain Relief, a human over the counter drug labeled by A.t.s. Laboratories, Llc. This gel is formulated for topical use and contains lidocaine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by A.t.s. Laboratories, Llc on July 01, 2015. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
This medication is used to prevent and relieve pain during certain medical procedures (such as inserting a tube into the urinary tract). It is also used to numb the lining of the mouth, throat, or nose before certain medical procedures (such as intubation). Lidocaine jelly is also used to relieve pain caused by swelling of the urinary tract (urethritis). It works by numbing certain areas of the body that are moist. Lidocaine belongs to a class of drugs known as local anesthetics.
How is this A.t.s. Laboratories, Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 70188000501. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.